Canada

BMI View: Patented medicine sales accounted for 62% of total Canadian pharmaceutical sales in 2011 and this subsector's share of total pharmaceutical sales (prescription drugs and over-the-counter... 2012-03-29

BMI View: Multinational pharmaceutical companies will face ongoing pricing pressure in Canada's generic drug sector due to impending legislation. Local pharmacies will take the brunt... 2012-03-05

BMI View: Canada's aging population, increasing demand for high-tech devices from healthcare professionals and comparatively healthy public finances will enable the medical device sector... 2012-02-13

BMI Core View: Personalised medicines will play a greater role in the treatment of patients. They offer fewer side-effects and treat illnesses more efficiently than wide-spectrum therapeutics.... 2012-02-10

BMI View: Pharmaceutical companies will benefit from the growth in the number of doctors in Canada due to the potential increase in prescriptions and consumers' preference for patented... 2011-12-20

BMI View: Long viewed as a refuge for leading drugmakers, government cost-cutting measures, including the promotion of generics and branded product price reductions, are expected to... 2011-11-21

BMI Core View: Drugmakers based in emerging markets will expand their presence in developed countries. Firms in developing countries enjoy low operating costs but have historically... 2011-11-10

BMI View: While news that Canadian authorities have tightened public drug plans will come as no surprise, reimbursement trends favouring cost-effective studies over clinical success... 2011-10-26

BMI View: While viewed as a positive first step, we do not believe a proposed drug monitoring system will let Canadian drugmakers off the hook from the government's ongoing calls for... 2011-10-18

BMI View: After more than a year of back-door meetings, the ongoing general trade talks between Canada and the European Union could deteriorate if Ottawa resists calls from multinational... 2011-10-04